ANALYTICAL VALIDATION OF FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR CSF BETA-AMYLOID 1-40 AND 1-42 ANALYSIS FOR USE IN CLINICAL TRIALS

Emeric Chassaing; Victor Herbst; Britta Brix; Hugo Marcel Vanderstichele; Philippe Vergnaud; Tanja Schubert; Mélanie Bodnar-Wachtel

首页> 外文期刊>Alzheimer’s & dementia: the journal of the Alzheimer’s Association >ANALYTICAL VALIDATION OF FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR CSF BETA-AMYLOID 1-40 AND 1-42 ANALYSIS FOR USE IN CLINICAL TRIALS

【24h】

ANALYTICAL VALIDATION OF FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR CSF BETA-AMYLOID 1-40 AND 1-42 ANALYSIS FOR USE IN CLINICAL TRIALS

机译：用于CSFβ-淀粉样蛋白1-40和1-42分析的全自动化学发光免疫测定的分析验证用于临床试验的分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Alzheimer’s & dementia: the journal of the Alzheimer’s Association》 |2018年第7期|共1页
作者
Emeric Chassaing; Victor Herbst; Britta Brix; Hugo Marcel Vanderstichele; Philippe Vergnaud; Tanja Schubert; Mélanie Bodnar-Wachtel;
展开▼
作者单位

Bioclinica Lab;

Euroimmun AG;

Euroimmun AG;

ADx NeuroSciences;

Bioclinica Lab;

Bioclinica Lab;

Bioclinica Lab;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. ANALYTICAL VALIDATION OF FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR CSF BETA-AMYLOID 1-40 AND 1-42 ANALYSIS FOR USE IN CLINICAL TRIALS [J] . Emeric Chassaing, Victor Herbst, Britta Brix, Alzheimer’s & dementia: the journal of the Alzheimer’s Association . 2018,第7期

机译：用于CSFβ-淀粉样蛋白1-40和1-42分析的全自动化学发光免疫测定的分析验证用于临床试验的分析
2. Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays [J] . Deng Lingyan, Xiong Zhigang, Li Huijun, Clinical Biochemistry . 2018,第期

机译：用全自动化学发光免疫测定，中国汉族人群醛固酮和肾素参考区间的分析验证及调查
3. A Method for Evaluating the Level of Soluble beta-Amyloid((1-40/1-42)) in Alzheimer's Disease Based on the Binding of Gelsolin to beta-Amyloid Peptides [J] . Yu Yanyan, Zhang Lin, Li Chenglin, Angewandte Chemie . 2014,第47期

机译：一种基于凝溶胶蛋白与β-淀粉样蛋白肽结合的阿尔茨海默病中可溶性β-淀粉样蛋白（（1-40 / 1-42））水平的评价方法
4. AN LC-MS/MS-BASED METHOD FOR QUANTIFICATION OF Aβ1-38, Aβ1-40 AND Aβ1-42 IN CSF OF AD PATIENTS AND HEALTHY CONTROLS [C] . Josef Pannee, E. Portelius, M. Oppermann, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：基于LC-MS / MS的用于定量Aβ1-38，Aβ1-40和Aβ1-42中的AD患者和健康对照的方法
5. Patient motivation for participation in clinical trials for depression: Development and validation of the Motivation for Clinical Trials Inventory -Depression (MCTI-D) [D] . Loraas, Emily L. 2006

机译：参与抑郁症临床试验的患者动机：临床试验动机-抑郁症（MCTI-D）的开发和验证
6. Clinical Performance Evaluation of Four Automated Chemiluminescence Immunoassays for Hepatitis C Virus Antibody Detection [O] . Sinyoung Kim, Jeong-Ho Kim, Seoyoung Yoon, 2008

机译：四种自动化学发光免疫分析法检测丙型肝炎病毒抗体的临床性能评价
7. Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF [O] . Hulstaert F, Blennow K, Ivanoiu A, 1999

机译：使用β-淀粉样蛋白（（1-42））和tau在脑脊液中改善对AD患者的辨别力

ANALYTICAL VALIDATION OF FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR CSF BETA-AMYLOID 1-40 AND 1-42 ANALYSIS FOR USE IN CLINICAL TRIALS

著录项

相似文献

相关主题

期刊订阅